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Background: In continuous-ﬂow left ventricular assist device (LVAD) recipients, little is known about the relative
pump- and left ventricle-generated blood ﬂow (PBF and LVBF, respectively) contribution to peak systemic per-
fusion during incremental exercise and about how PBF/LVBF interplay and exercise capacity may be affected
by pump speed increase.
Methods: Twenty-two LVAD recipients underwent ramp cardiopulmonary exercise tests at ﬁxed and increasing
pump speed (+1.5% of baseline speed/10Wworkload increase), echocardiography andNT-proBNPdosage. Peak
systemic perfusion was peak VO2/estimated peak arterio-venous O2 difference, and LVBFwas systemic perfusion
minus PBF provided by LVAD controller. A change of peak percentage of predicted VO2max (Δpeak%VO2) ≥3 in
increasing- vs. ﬁxed-speed test was considered signiﬁcant.
Results: Tricuspid annular plane systolic excursion (TAPSE) and NT-proBNP were signiﬁcantly lower and higher,
respectively, in Δpeak%VO2 b 3 than≥3. A LVBF contribution to systemic perfusion signiﬁcantly larger than that
of PBF was observed in Δpeak%VO2 ≥ 3 vs. b3 in ﬁxed-speed test, which was further ampliﬁed in increasing-
speed test (2.4 ± 1.7 l/min vs. 2.0 ± 1.5 l/min and 0.8 ± 2.2 l/min vs. 1.3 ± 2.3 l/min, respectively, p for trend
b0.0005). Among several clinical-instrumental parameters, logistic regression selected only TAPSE N13 mm as
a predictor of Δpeak%VO2 ≥ 3.
Conclusions: A signiﬁcant LVBF contribution to peak systemic perfusion and pump speed increase-induced peak
VO2 improvement was detectable only in patients with a more preserved right ventricular systolic function and
stable hemodynamic picture. Theseﬁndings should be taken into considerationwhendesigning LVAD controllers
aiming to increase pump speed according to increasing exercise demands.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Continuous-ﬂow left ventricular assist devices (LVADs) are increas-
ingly used as destination therapy in end-stage chronic heart failure
(CHF), and patients can be supported by LVADs in their habitual activi-
ties even for some years [1,2]. In such a clinical setting, knowledge of ex-
ercise pathophysiology plays an important role. LVAD implantationF, pump-generated blood ﬂow;
id annular plane systolic excur-
ssociation; CaO2, resting arterial
stolic pressure.
boratory, Cardiac Rehabilitation
ﬁc Institute of Veruno, Via per
711; fax: +39 322 830294.
ni).
and Ltd. This is an open access articledetermines a peculiar exercise hemodynamic picture, where two
pumps, i.e., LVAD and native left ventricle, can act in parallel to generate
systemic perfusion [3]. Even in the presence of a ﬁxed pump speed,
some increase of PBF is actually detectable during exercise testing and
habitual activities [3–6], as both exercise-induced tachycardia and aug-
mentation of telediastolic left ventricular pressure do reduce the pres-
sure gradient across the pump [3,5]. The contribution of native left
ventricle to systemic perfusion can also increase during exercise, due
to augmented venous return, decrease of peripheral resistances and ac-
tivation of sympathetic drive [3]. However, notwithstanding the device
boost to O2 delivery, LVAD-implanted patients often suffer from a re-
duced exercise capacity [3,7,8], due to the limited ability of both the
LVAD and the dysfunctioning left ventricle to adapt to increasing ener-
getic demands. In this regard, scant data are available as to the relative
contribution of PBF and left ventricle-generated blood ﬂow (LVBF) tounder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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be affected by pump speed increase. In addition, few studies have eval-
uated the effects of pump speed increase on exercise capacity in LVAD-
implanted patients, showing either no change or a signiﬁcant increase
[9–11].
The aim of this studywas to evaluate the relative contribution of PBF
and LVBF to peak systemic perfusion in a group of LVAD recipients with
severely reduced exercise capacity, tested at two different pump speeds
during incremental exercise. In addition, we evaluated the effects of
pump speed increase on peak aerobic power (peak VO2) in this popula-
tion and sought for possible clinical–instrumental predictors of peak
VO2 increase in response to changes in pump speed.
2. Methods
2.1. Study population
Twenty-two patients implanted with LVAD were studied. Inclusion
criteria were: 1) clinical stability, deﬁned as no change in NYHA class,
absence of hospitalization and stable medical treatment during the
month prior to evaluation; 2) LVAD implanted≥30 days prior to evalu-
ation; 3) cardiopulmonary exercise tests stopped for fatigue and/or dys-
pnea with peak respiratory exchange ratio of ≥1.05; 4) absence of
angina and/or instrumentally inducible myocardial ischemia and/or ev-
idence of complex ventricular arrhythmias. Indication for LVAD implan-
tation was persistent hemodynamic decompensation not responsive to
intensivemedical therapy. No patient had undergone aortic valve sutur-
ing at LVAD implantation. The protocol was approved by the Central
Ethics Committee of the S. Maugeri Foundation, IRCCS and informed
written consent was obtained from all participants in the study.
2.2. Echocardiographic evaluation
Within 7 days prior to ergometric evaluation, all participants
underwent an echocardiogram according to reported standards in pa-
tients with LVAD [12]. Left ventricular cavity areas at end-diastole and
end-systole from the apical 4- and 2-chamber views were obtained.
The modiﬁed Simpson's rule was used to obtain biplane left ventricularTable 1
Demographic and clinical characteristics.
Total group
(n = 22)
Age (years) 57 ± 9
Male gender (n, %) 21 (95)
BMI (kg/m2) 24.99 ± 3.71
LVAD type (n, %) HM 9 (41)
HW 8 (36)
INC 5 (23)
Indication for LVAD implantation (n, %) BR 15 (68)
DT 6 (32)
Time since implantation (days) 156 ± 186
Etiology I 14 (64)
D 8 (36)
β-Blockers (n, %) 21 (95)
LVEF (%) 26 ± 8
TAPSE (mm) 12.3 ± 2.7
PASP (mm Hg) 32 ± 8
Hematocrit (%) 36 ± 3
NT-proBNP (pg/ml) 2825 ± 2907
Values are n (%) or mean ± standard deviation.
Δpeak%VO2 ≥ 3 = increase of peak % predicted VO2max between ﬁxed and increasing pump sp
increasing pump speed tests b3; BMI = bodymass index; LVAD = left ventricular assist devic
decision/recovery; DT = destination therapy; I = ischemic cardiomyopathy; D = dilative car
systolic excursion; PASP = pulmonary arterial systolic pressure.
a P b 0.05 vs. Δpeak%VO2 ≥ 3.
b P b 0.08 vs. Δpeak%VO2 ≥ 3.volumes, and left ventricular ejection fractionwas derived from the stan-
dard equation. Tricuspid annular plane systolic excursion (TAPSE) was
used as a descriptor of right ventricular systolic function. To obtain
TAPSE, the apical 4-chamber view was used, and an M-mode cursor
was placed through the lateral tricuspid annulus in real time. Ofﬂine,
the brightness was adjusted to maximize the contrast between the M-
mode signal arising from the tricuspid annulus and the background.
TAPSE was measured as the peak excursion of the tricuspid annulus
(mm) from the end of diastole to the end of systole, with values
representing TAPSE being averaged over 3 to 5 beats. Right ventricular
systolic pressurewas determined from the tricuspid regurgitation jet ve-
locity using the simpliﬁed Bernoulli equation, and this value combined
with an estimate of the right atrial pressure by the diameter and collaps-
ibility of the inferior vena cava to yield pulmonary arterial systolic pres-
sure (PASP).2.3. Ergometric evaluation
All tests were performed on an electromagnetic bicycle ergometer
(Ergo-metrics 800S; Sensormedics; Yorba Linda, CA, USA). Each patient
underwent two ramp cardiopulmonary exercise tests, one with ﬁxed
LVAD speed (as set soon after implantation by the cardiac surgery team
to allowmaximum hemodynamic support at rest while avoiding suction
events) and onewith increasing LVAD speed. The two tests were separat-
ed by 48h and their sequencewas randomized. Brassard et al. [9] recently
used a 400 rpm/30 W increase of pump speed during incremental exer-
cise, equal to an average percent increase of 1.5%/10 W with respect to
baseline. The latter ﬁgure was used as the criterion for pump speed in-
crease in the present study, given the presence of 3 types of LVAD
(Table 1) with different baseline pump speeds (HeartWare, range
2400–2800 rpm; HeartMate II, range 8600–9400 rpm; Incor, range
6850–7500 rpm). Heart rate and 12-lead ECG were monitored con-
tinuously during the test (CASE; GE Healthcare; Fairﬁeld, CT, USA).
After a 1-min 20 W warm-up period, a ramp protocol of 5, 7, or
10 W/min at a pedaling rate of 60 rev/min was started, and respira-
tory gas exchange measurements were obtained breath-by-breath
(Vmax29; SensorMedics; Yorba Linda, CA, USA). Peak VO2 was the
mean VO2 value observed during the last 30 s of the exercise period.Δpeak%VO2 ≥ 3
(n = 13)
Δpeak%VO2 b 3
(n = 9)
56 ± 8 57 ± 10
13 (100) 8 (89)
25.74 ± 3.27 23.90 ± 4.22
HM 6 (46)
HW 3 (23)
INC 4 (31)
HM 3 (33)
HW 5 (55)
INC 1 (12)
BR 11 (85)
DT 2 (15)
BR 5 (55)
DT 4 (45)
168 ± 171 138 ± 215
I 8 (61)
D 5 (39)
I 6 (66)
D 3 (34)
12 (92) 9 (100)
26 ± 3 25 ± 12
13.4 ± 2.3 10.7 ± 2.3a
28 ± 4 38 ± 9a
37 ± 4 34 ± 2
1961 ± 1889 4073 ± 3724b
eed tests≥3; Δpeak%VO2 b 3 = increase of peak % predicted VO2max between ﬁxed and
e; HM = HeartMate II; HW = HeartWare; INC = Incor; BR = bridge to transplantation/
diomyopathy; LVEF = left ventricular ejection fraction; TAPSE = tricuspid annular plane
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was evaluated excluding, when present, its ﬁnal nonlinear portion
due to acidotic ventilatory drive.
2.4. Hemodynamic evaluation
Systemic perfusionwas calculated by the Fick's principle usingmea-
sured VO2 and estimated arterio-venous O2 difference values. Resting
arterial O2 content (CaO2) was
Resting CaO2 (ml/dl) = Hb ∗ 1.34 ∗ SaO2
were Hb is hemoglobin concentration in g/dl, 1.34 is hemoglobin O2
binding capacity in ml O2/g Hb and SaO2 is hemoglobin oxygen satura-
tion (assumed equal to 98%). Due to the exercise-induced hemo-
concentration, a value of Hb increased by 0.5 g/dl with respect to
baseline [Mezzani A, unpublished data, 2013] was used to calculate
peak CaO2. According to available data [13], resting and peak exercise
O2 extraction in advanced CHF is around 40% and 80%, respectively; in
addition, a similar peak O2 extraction has been reported in LVAD
patients [3]. These values were thus adopted to calculate resting and
peak systemic perfusion in l/min using the Fick's principle. PBF values
in l/minwere obtained by the device controller and LVBFwas the differ-
ence between systemic perfusion and PBF values.
2.5. Blood sampling procedures and hormonal assays
All patients had a measurement of plasma NT-pro-BNP. Venous
blood samples were obtained after at least 30 min of rest and collected
in tubes containing an ethylenediamine tetraacetic acid buffer. They
were immediately placed on ice and centrifuged at 4 °C. Plasma samples
were stored at−20 °C until assay. The time between NT-pro-BNP and
ergometric evaluation was 4 ± 3 days.
2.6. Statistics
Unpaired andpaired t-tests and repeatedmeasuresANOVAwere used
to compare the means of quantitative variables, whereas the chi-squared
test with Fisher's exact test was employed for qualitative data. Stepwise
logistic regression analysis was used to assess predictors of peak VO2
change between increasing- and ﬁxed-speed tests. Given the quite wide
age range of the study population (35–69 years), change of peak VO2
expressed as a percentage of predicted VO2max (Δpeak%VO2), i.e.
corrected for sex and age, was used as categorical dependent variable. A
3% cutoff value (≥3% / b3%) was chosen because equal to the median ofTable 2
Haemodynamic parameters.
Total group
(n = 22)
Δp
(n
Fixed speed test Increasing speed test Fix
Resting pump speed (rpm) HM 9156 ± 240 9156 ± 240 91
HW 2628 ± 133 2628 ± 133 26
INC 7230 ± 277 7230 ± 277 71
Peak pump speed (rpm) HM 9156 ± 240 9622 ± 307 91
HW 2628 ± 133 2779 ± 123 26
INC 7230 ± 277 8090 ± 296 71
Resting PBF (l/min) 4.2 ± 0.8 4.2 ± 0.8
Resting systemic perfusion (l/min) 3.9 ± 0.9 4.0 ± 1.0
Peak PBF (l/min) 5.4 ± 0.8 5.9 ± 0.8a
Peak systemic perfusion (l/min) 7.1 ± 1.8b 7.6 ± 1.9a,b
Values are mean ± standard deviation.
Δpeak%VO2 ≥ 3 = increase of peak % predicted VO2max between ﬁxed and increasing pump s
increasing pump speed tests b3; HM = HeartMate II; HW = HeartWare; INC = Incor; PBF =
a P b 0.005 vs. ﬁxed pump speed.
b P b 0.001 vs. peak PBF.the study population and larger than our laboratory's repeated-test vari-
ability in CHF patients with severely depressed peak VO2 [14]. The inde-
pendent variables forced into the model included time since LVAD
implantation (≤180 days / N180 days), left ventricular ejection fraction,
hematocrit, NT-proBNP, peak heart rate and PBF at increasing-speed
test, LVAD type (HeartMate II yes/no, HeartWare yes/no, Incor yes/no)
and TAPSE (≤13 mm / N13 mm). The 13 mm TAPSE cutoff was the me-
dian value of the study population, and corresponds to the value separat-
ing light frommoderate-to-severe depression of right ventricular systolic
function [15].
The level of statistical signiﬁcance was set at a 2-tailed P-value of
≤0.05. The StatView® 5.0.1. (SAS Institute, Inc.; Cary, NC) software
package was used for statistical calculations.
3. Results
Demographic and clinical characteristics of the study population are
shown in Table 1. HeartWare LVADs were relatively more represented
in the Δpeak%VO2 b 3 group, even if the difference was not statistically
signiﬁcant. TAPSEwas signiﬁcantly lower and PASP and NT-proBNP sig-
niﬁcantly higher, respectively, in Δpeak%VO2 b 3 than in Δpeak%VO2
≥ 3, testifying to a more compromised hemodynamic picture in the for-
mer group (Table 1).
3.1. Contributors to systemic perfusion at ﬁxed vs. increasing pump speed
No patient suffered from suction episodes and/or complex ventricu-
lar arrhythmias during exercise tests. By design, the pump speed in-
crease during the increasing-speed test was on average equal to 7%
and 6% in Δpeak%VO2 ≥ 3 and b3, respectively.
In the whole study group, resting systemic perfusion was similar to
resting PBF irrespective of pump speed, peak %VO2 values and LVAD
type (Table 2). As expected, the PBF increase at peak exercisewas signif-
icantly larger in increasing- than in ﬁxed-speed tests (1.6 ± 0.7 l/min
vs. 1.2 ± 0.7 l/min, +33%, P b 0.005), with a similar behavior in
Δpeak%VO2 ≥ 3 and b3 irrespective of LVAD type (P for trend = 0.42)
(Fig. 1). On the contrary, a different trend of change of LVBFwas evident
between the 2 groups, with LVBF increasing by 20% at increasing- vs.
ﬁxed-speed test in Δpeak%VO2 ≥ 3 and decreasing by 39% in
Δpeak%VO2 b 3 (2.4 ± 1.7 l/min vs. 2.0 ± 1.5 l/min and 0.8 ±
2.2 l/min vs. 1.3 ± 2.3 l/min, respectively, P for trend b0.0005)
(Fig. 1). In the increasing-speed test, this made LVBF provide around
one fourth of peak systemic perfusion in Δpeak%VO2 ≥ 3, but only
less than one tenth in Δpeak%VO2 b 3 (Table 2). Accordingly, peak
systemic perfusion increase in increasing- vs. ﬁxed-speed testseak%VO2 ≥ 3
= 13)
Δpeak%VO2 b 3
(n = 9)
ed speed test Increasing speed test Fixed speed test Increasing speed test
33 ± 301 9133 ± 301 9200 ± 0 9200 ± 0
20 ± 203 2620 ± 203 2632 ± 100 2632 ± 100
62 ± 269 7162 ± 269 7500 ± 0 7500 ± 0
33 ± 301 9566 ± 344 9200 ± 0 9733 ± 231
20 ± 203 2743 ± 212 2632 ± 100 2800 ± 51
62 ± 269 8112 ± 268 7500 ± 0 8000 ± 0
4.2 ± 0.9 4.3 ± 0.9 4.1 ± 0.6 4.2 ± 0.6
4.0 ± 0.9 4.1 ± 1.0 3.9 ± 0.9 3.8 ± 1.0
5.3 ± 0.8 5.8 ± 0.7a 5.7 ± 0.8 6.0 ± 1.0a
7.2 ± 1.9b 8.1 ± 2.0a,b 6.9 ± 1.8 6.8 ± 1.7
peed tests ≥3; Δpeak%VO2 b 3 = increase of peak % predicted VO2max between ﬁxed and
pump blood ﬂow.
Fig. 1. Partitioning of contributors to systemic perfusion increase during incremental exer-
cise in left ventricular assist device recipients. Peak pump blood ﬂow (PBF) increased sig-
niﬁcantly during increasing-speed exercise in both Δpeak%VO2≥ 3 and b3, whereas peak
left ventricular blood ﬂow (LVBF) was signiﬁcantly increased in Δpeak%VO2 ≥ 3 and de-
creased in Δpeak%VO2 b 3. See text for further details. * = P b 0.05 vs. ﬁxed speed; ** =
P b 0.05; *** = P b 0.11.
Table 4
Predictors of Δpeak%VO2 ≥ 3 at logistic regression analysis. Δpeak%VO2 ≥ 3% =
difference of peak % predicted VO2max between ﬁxed and increasing pump speed
tests ≥3; CI = conﬁdence interval; LVEF = left ventricular ejection fraction; PBP
incr. = pump blood ﬂow at increasing-speed test; Peak HR = peak heart rate at
increasing-speed test; TAPSE = tricuspid annular plane systolic excursion.
Chi-square P-value Odds ratio (95% CI)
LVEF (%) 0.01 0.90 0.99 (0.77–1.25)
Peak PBP incr. (l/min) 0.01 0.76 1.40 (0.14–13.7)
Time since LVAD
implantation ≤180 days
0.26 0.61 6.97 (0.00–120.21)
Peak HR incr. (bpm) 0.36 0.55 1.04 (0.92–1.17)
NT-proBNP (pg/ml) 0.75 0.39 1.00 (0.99–1.00)
Hematocrit (%) 0.97 0.32 1.41 (0.71–2.80)
TAPSE N13 mm 3.29 0.05 34.65 (0.75–159.98)
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Δpeak%VO2 b 3 (−2%) (P for trend b0.001 — Fig. 1 and Table 2).
These ﬁndings did not differ between different LVAD types.3.2. Peak VO2 at ﬁxed vs. increasing pump speed
In thewhole study population, peak VO2 and peak %VO2were signif-
icantly higher in increasing- than in ﬁxed-speed tests, irrespective of
LVAD type; by design, such an increase was present in Δpeak%VO2 ≥ 3
but not in Δpeak%VO2 b 3 (P for trend b0.0001) (Table 3). VE/VCO2
slope and peak heart rate were not affected by pump speed changes
(Table 3).
At stepwise logistic regression analysis testing Δpeak%VO2 ≥ 3 pre-
dictors, LVAD type did not enter the model due to colinearity and only
TAPSE N13 mm was signiﬁcantly associated with the dependent vari-
able (Table 4).Table 3
Gas exchange and ergometric parameters.
Total group
(n = 22)
Δpeak%VO
(n = 13)
Fixed pump speed Increasing pump speed Fixed pum
Resting VO2 (ml/kg/min) 3.7 ± 0.5 3.7 ± 0.6 3.7 ± 0.5
Peak VO2 (ml/kg/min) 12.8 ± 2.2 13.7 ± 2.6a 12.8 ± 2.5
Peak %pred·VO2max 44 ± 8 47 ± 9a 43 ± 8
Peak RER 1.16 ± 0.11 1.17 ± 0.12 1.14 ± 0.1
VE/VCO2 slope 40.9 ± 6.1 39.9 ± 6.5 41.7 ± 6.8
Peak HR (bpm) 114 ± 20 115 ± 20 117 ± 21
Values are mean ± standard deviation.
Δpeak%VO2 ≥ 3 = increase of peak % predicted VO2max between ﬁxed and increasing pump sp
increasing pump speed tests b3; RER = respiratory exchange ratio; VE = ventilation; HR = h
a P b 0.05 vs. ﬁxed pump speed.4. Discussion
Our results show that a signiﬁcant LVBF contribution to peak exer-
cise systemic perfusion can be observed in LVAD recipients. In patients
with quite a preserved right ventricular systolic function and lower neu-
rohormonal activation, such a contribution is signiﬁcantly larger than
that provided by the LVAD. In addition, these patients are able to in-
crease both their LVBF and peak VO2 to a larger extent than those
more hemodynamically compromised in response to pump speed in-
crease. These ﬁndings let hypothesize a better management of systemic
venous return during incremental exercise in LVAD-implanted patients
with a more preserved right ventricular function and hemodynamic
balance.4.1. Contributors to systemic perfusion at ﬁxed vs. increasing pump speed
Resting PBF is known to be dictated by the pump speed and the pres-
sure head across the pump [16]. In our population, PBF did not differ
from systemic perfusion at rest (Table 2), with values consistent with
resting cardiac output of elderly beta-blocked CHF patients [17]. More-
over, our ﬁndings are in agreement with previously reported data indi-
cating no differences between resting PBF and systemic perfusion
measured by thermodilution technique [3,18]. During exercise, a sponta-
neous increase of PBF is usually observed due to the reduction of the
pressure gradient across the pump. This occurs due to tachycardia-
induced prolongation of the time spent in systole and to augmentation
of telediastolic left ventricular pressure [3,5]. Our data ﬁt well with this
picture, showing an average increase of PBF equal to 1.2 l/min and
1.6 l/min in ﬁxed- and increasing-speed tests, respectively (Fig. 1 and
Table 2), consistent with that reported by Jacquet et al. [3]. Peak PBF
did not differ between Δpeak%VO2 ≥ 3 and Δpeak%VO2 b 3 and the
PBF increase vs. rest was quite modest both in ﬁxed- and increasing-
speed tests (Table 2), an expected ﬁnding based on the reduced LVAD
preload sensitivity [19].2 ≥ 3 Δpeak%VO2 b 3
(n = 9)
p speed Increasing pump speed Fixed pump speed Increasing pump speed
3.8 ± 0.5 3.7 ± 0.5 3.6 ± 0.7
14.4 ± 2.8a 12.7 ± 1.9 12.5 ± 1.8
49 ± 9a 45 ± 9 44 ± 9
0 1.13 ± 0.10 1.20 ± 0.12 1.22 ± 0.13
40.7 ± 7.4 39.8 ± 5.3 38.9 ± 5.0
118 ± 18 109 ± 19 110 ± 22
eed tests ≥3; Δpeak%VO2 b 3 = increase of peak % predicted VO2max between ﬁxed and
eart rate.
Fig. 2.Models of cardio-circulatory system dynamics during incremental exercise in left
ventricular assist device recipients. Panel A shows a right ventricle still able to cope
with the systemic venous return,with no signiﬁcant shift of blood volume between the ar-
terial and venous compartments. Panel B shows ‘discordant’ failure of the right ventricle
vs. the left ventricle/LVAD system, in the presence of signiﬁcant right ventricular systolic
dysfunction andhigh systolic pulmonary artery pressure. The net effect is a shift of volume
from the arterial to the venous compartment, with a resultant lower systemic perfusion
than in panel A. See text for further details. RV = right ventricle; LV = left ventricle;
PASP = pulmonary arterial systolic pressure; CV = venous capacitance; CA = arterial
capacitance.
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fusion values were signiﬁcantly higher than those of peak PBF in both
ﬁxed- and increasing-speed tests (Table 2), approaching cardiac output
values reported in CHF patients for similar peak work rates [17]. This
testiﬁes to a signiﬁcant LVBF contribution to systemic perfusion increase
during incremental exercise in LVAD patients. However, amarkedly dif-
ferent pattern of LVBF/PBF interaction between Δpeak%VO2 ≥ 3 and
Δpeak%VO2 b 3 was evident. Namely, at peak ﬁxed-speed exercise,
LVBF contribution to systemic perfusion increase was signiﬁcantly
larger than that of PBF in Δpeak%VO2 ≥ 3, which did not happen in
Δpeak%VO2 b 3 (Fig. 1). This pattern was even ampliﬁed in the
increasing-speed tests, with peak LVBF further increasing inΔpeak%VO2
≥ 3 but signiﬁcantly decreasing inΔpeak%VO2 b 3 (Fig. 1),with PBF pro-
viding almost the whole peak systemic perfusion in the latter group
(Table 2). Importantly, Δpeak%VO2 ≥ 3 had a better right ventricular
systolic function and lower pulmonary pressures and NT-proBNP levels
than Δpeak%VO2 b 3, i.e. a less compromised hemodynamic and neuro-
hormonal picture. These ﬁndings highlight a possible role played by the
right ventricle in determining the hemodynamic response to exercise in
LVAD patients. This would especially be true when the right ventricle isor starts functioning on the ﬂat portion of the cardiac function curve
[20]. In such a situation (panel B of Fig. 2), a severely dysfunctioning
right heart could not keep pace with the systemic venous return rate,
and some dynamic shift of blood volume from the arterial to the venous
compartment would occur [21,22], so reducing the blood content of the
arterial compartment, i.e. systemic perfusion. This hypothesis is indi-
rectly supported by data from Hayward et al. [16], who found suction
episodes and/or ventricular arrhythmias occurring during pump speed
increase at rest only in patients with moderate-to-severe right ventric-
ular dysfunction. Protocols evaluating exercise-induced changes in both
central venous pressure and telediastolic left ventricular pressure in an
experimental setting similar to that of the present study may help to
further clarify this issue.
4.2. Peak VO2 at ﬁxed vs. increasing pump speed
In a group of 8 LVAD patients with preserved exercise capacity, Bras-
sard et al. [9] evaluated the effects of a pump speed increase algorithm
similar to that used in the present study on peak work rate, ﬁnding no
changes; however, no information about peak VO2 was provided by
these authors. On the other hand, Salamonsen et al. [10] measured
peak VO2 in 10 LVAD patients with severely reduced exercise capacity
exercising at 80%, 100% and 130% of baseline pump speed, ﬁnding a sta-
tistically signiﬁcant 9% peak VO2 increase between exercise tests con-
ducted at the lowest and highest pump speed. Finally, Jung et al. [11]
recently found a signiﬁcant 9% increase of peak VO2 after a pump
speed increase of 16% during incremental exercise in a group of 14
LVAD patients. Our data demonstrate a peak VO2 increase (7%) in the
whole study population quite similar to that reported by Salamonsen
and Jung, however occurring after a much lower percent pump speed
increase. Interestingly, according to our data a TAPSE ≤13 mm was
the only independent predictor of a peak%VO2 change b3 among several
clinical–instrumental parameters (Table 4). This ﬁnding is not unex-
pected, as right ventricular function is known to be related to functional
capacity much more than the left ventricular one in a wide range of
pathophysiological pictures, i.e. chronic heart failure [23], repaired te-
tralogy of Fallot [24], chronic obstructive pulmonary disease [25] and
pulmonary hypertension [26]. As a whole, these ﬁndings lend support
to the pathophysiological picture proposed in Fig. 2. Of note, starling-
like controllers designed to provide automatic PBF adaptations to exer-
cise are usually tested assuming bothno/minimal left ventricular contri-
bution to systemic perfusion and a venous return to the left heart not
signiﬁcantly limited by the right ventricle [11,27]. The results of the
present study suggest that such assumptions may not always prove to
be true in the real world of LVAD recipients.
4.3. Study limitations
We acknowledge that measuring systemic perfusion invasively dur-
ing the exercise tests would have provided more reliable information;
conversely, right-heart catheterizationmayhave resulted in less ﬂexible
experimental conditions and less certain attainment of maximal or
near-maximal effort. In any case, as far as systemic perfusion calculation
is concerned, the only estimated parameter was peak peripheral O2 ex-
traction, which is known to be far more predictable than peak VO2 dur-
ing incremental exercise in both normal subjects and patients with CHF
[13,28]. In this regard, the estimated increase of hemoglobin level equal
to 0.5 g/l at peak exercise with respect to baseline (11.8 ± 1.2 g/l) used
in the present study corresponds to the 4% average hemoconcentration
observed in our laboratory when performing arterial blood gases analy-
sis during exercise in CHF patients. In addition, the assumption of a nor-
mal resting hemoglobin oxygen saturation with no signiﬁcant changes
at peak incremental exercise is expected in stable LVAD patients with
no associated lung disease. Also PBF was an estimated value, based on
speed settings and power consumption, and must be interpreted with
some caution. We evaluated patients implanted with 3 different LVAD
45A. Mezzani et al. / IJC Heart & Vessels 4 (2014) 40–45models. This may have affected the pump hemodynamic response dur-
ing exercise, in the light of possible differences in pump preload sensi-
tivity [19] and different baseline pump speeds. However, study data
did not differ in patients with different LVAD types, nor was LVAD
type retained in the Δpeak%VO2 logistic regression predictive model,
which seems to rule out possible signiﬁcant effects of LVAD type on ex-
ercise hemodynamics. Finally, the sample size of the present study was
conditioned by the scarcity of LVAD patients; however, our preliminary
data will enable the design of adequately powered future protocols.
5. Conclusions
A signiﬁcant native left ventricle contribution to peak exercise sys-
temic perfusion is detectable in LVAD recipients. Patients with quite a
preserved right ventricular systolic function and stable hemodynamic
picture, demonstrate to be able to increase their native left ventricle
blood ﬂow and peak VO2 in response to pump speed increase to a larger
extent than thosemore hemodynamically compromised. These ﬁndings
let hypothesize a better management of systemic venous return during
incremental exercise in patients still provided with some amount of
right ventricular preload reserve, in a context of hemodynamic stability.
These results should be taken into consideration when conceiving and
designing LVAD controllers able to increase pump speed in response
to increasing exercise demands.
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